TELA Bio, Inc. (TELA)

NGM – Real Time Price. Currency in USD

0.78

-0.01 (-1.73%)

Market open: Aug 12, 2026, 9:30 AM EDT

0.77

-0.02 (-2.25%)

Previous after-hours: Aug 11, 2026, 7:38 PM EDT

05.08.2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Board of Directors of TELA Bio approved inducement grants of stock options to purchase an aggregate of 2,370,000 shares of its common stock and restricted stock units covering 500,000 shares of its common stock to the Company's newly-hired Chief Executive Officer, Heather Getz, with a grant date of August 3, 2026 (the "Getz Grant Date"). The stock options consist of (i) stock options to purchase 1,365,000 shares of common stock (the “Standard Options”) and (ii) premium-priced stock options to purchase 1,005,000 shares of common stock (the “Premium-Options”). Additionally, the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 95,500 shares of its common stock to 11 newly-hired employees, with a grant date of August 4, 2026. The stock options and the restricted stock units discussed above were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of Ms. Getz's and each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.

04.08.2026

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

MALVERN, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced that the Board of Directors (the “Board”) has appointed Heather Getz as Chief Executive Officer and Director, effective today.

Videos

No Data

There is no data to display

Press releases

05.08.2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04.08.2026

TELA Bio, Inc. (TELA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

TELA Bio, Inc. (TELA)

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Videos

No Data

Press releases

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Videos

No Data

Press releases

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Search stocks

TELA Bio, Inc. (TELA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

TELA Bio, Inc. (TELA)

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Videos

No Data

Press releases

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

Videos

No Data

Press releases

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director